Vascular disease

Thrombolytic shortage looms due to inappropriate use in stroke patients

Cardiologists are facing a shortage of the thrombolytic agent tenecteplase (Metalyse) because limited supplies are being used inappropriately in place of alteplase for the treatment of acute stroke. Tenecteplase is being adopted with enthusiasm for the treatment of stroke because of its more convenient single bolus dosing compared to the infusion needed for alteplase, according ...

Already a member?

Login to keep reading.

© 2021 the limbic